Figure 2From: The influence of statin-fibrate combination therapy on lipids profile and apolipoprotein A5 in patients with acute coronary syndromePercentage of patients achieving therapeutic goal in lipids. * p < 0.05. 12 week versus baseline in the group; § p < 0.05, combination group versus statin group. Triple, three lipids biomarker including LDL-C,TG and HDL-C.Back to article page